Joseph Longo

14PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer diagnosisMedical biochemistry - amino acids and metabolitesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 09, 2025
Dietary restriction reprograms CD8+ T cell fate to enhance anti-tumour immunity and immunotherapy responses.

Brandon M Oswald, Lisa M DeCamp, Joseph Longo

|Sep 08, 2025
An alternative route for β-hydroxybutyrate metabolism supports cytosolic acetyl-CoA synthesis in cancer cells.

Faith C Kaluba, Thomas J Rogers, Yu-Jin Jeong

|Jun 27, 2025
The prostacyclin receptor PTGIR is a NRF2-dependent regulator of CD8+ T cell exhaustion.

Michael S Dahabieh, Lisa M DeCamp, Brandon M Oswald

|Oct 28, 2024
Glucose-dependent glycosphingolipid biosynthesis fuels CD8+ T cell function and tumor control.

Joseph Longo, Lisa M DeCamp, Brandon M Oswald

|May 29, 2024
13C metabolite tracing reveals glutamine and acetate as critical in vivo fuels for CD8 T cells.

Eric H Ma, Michael S Dahabieh, Lisa M DeCamp

|Oct 25, 2022
Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins.

Jenna E van Leeuwen, Wail Ba-Alawi, Emily Branchard

Pageof 3